PA
PGC icon

PharVision Advisers’s Peapack-Gladstone Financial PGC Stock Holding History

PharVision Advisers’s Portfolio PGC Stock Details PGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,770
Closed -$216K – 503
2025
Q4 		$216K Buy
+7,770
New +$212K 0.11% 497

Other funds holding PGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's PGC Position: Q1 2026 in Review

PharVision Advisers sold out of Peapack-Gladstone Financial (PGC) in Q1 2026, closing a stake of 7,770 shares — an estimated $216K sold.

PharVision Advisers first reported a position in PGC in Q4 2025 and held it in 1 quarter. The position peaked at $216K in Q4 2025. 166 funds tracked by Wall St. Rank hold PGC as of Q1 2026.

  • PharVision Advisers reported no remaining Peapack-Gladstone Financial position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 7,770 Peapack-Gladstone Financial shares in Q1 2026, an estimated $216K.
  • PharVision Advisers first reported a position in Peapack-Gladstone Financial in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Peapack-Gladstone Financial position peaked at $216K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Peapack-Gladstone Financial as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.